StockData
CME Group Inc. logo

CME Group Inc. (CME) stock

CMENasdaqSecurity & Commodity Brokers, Dealers, Exchanges & ServicesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 23, 2026Score 11/3018% above fair value
$306.31−3.94 (-1.27%)

Close on Nov 19, 2026Market cap $109.64BP/E 25.1Yield 1.63%

CME free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

CME's free cash flow for the twelve months ending Sep 30, 2026 was $4.33B, up 6.1% year over year. For fiscal 2025 it was $4.19B, up 16.6% from the year before. Over ten years it grew 11.5% a year on average. The highest annual figure on record is $4.19B in fiscal 2025.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$4.19B+16.6%
FY2024Dec 31, 2024$3.60B+6.5%
FY2023Dec 31, 2023$3.38B+13.9%
FY2022Dec 31, 2022$2.97B+30.4%
FY2021Dec 31, 2021$2.28B-9.6%
FY2020Dec 31, 2020$2.52B+3.7%
FY2019Dec 31, 2019$2.43B+4.4%
FY2018Dec 31, 2018$2.32B+39.2%
FY2017Dec 31, 2017$1.67B+1.8%
FY2016Dec 31, 2016$1.64B+15.6%
FY2015Dec 31, 2015$1.42B+23.3%
FY2014Dec 31, 2014$1.15B-0.4%
FY2013Dec 31, 2013$1.15B+7.1%
FY2012Dec 31, 2012$1.08B-8.2%
FY2011Dec 31, 2011$1.17B-2.1%
FY2010Dec 31, 2010$1.20B+29.7%
FY2009Dec 31, 2009$925.20M-7.2%
FY2008Dec 31, 2008$997.10M+53.2%
FY2007Dec 31, 2007$650.70M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$1.07B+12.7%
Q2 FY2026Jun 30, 2026$923.50M-11.2%
Q1 FY2026Mar 31, 2026$1.24B+12.3%
Q4 FY2025Dec 31, 2025$1.10B+11.1%
Q3 FY2025Sep 30, 2025$949.70M-2.4%
Q2 FY2025Jun 30, 2025$1.04B+37.1%
Q1 FY2025Mar 31, 2025$1.10B+26.3%
Q4 FY2024Dec 31, 2024$991.70M-3.1%
Q3 FY2024Sep 30, 2024$973.20M+16.3%
Q2 FY2024Jun 30, 2024$758.70M+20.4%
Q1 FY2024Mar 31, 2024$872.90M-1.6%
Q4 FY2023Dec 31, 2023$1.02B+6.9%
Q3 FY2023Sep 30, 2023$836.80M+32.0%
Q2 FY2023Jun 30, 2023$629.90M+5.0%
Q1 FY2023Mar 31, 2023$887.20M+14.4%
Q4 FY2022Dec 31, 2022$957.10M+49.3%
Q3 FY2022Sep 30, 2022$633.80M+5.7%
Q2 FY2022Jun 30, 2022$599.70M+30.3%
Q1 FY2022Mar 31, 2022$775.70M+35.1%
Q4 FY2021Dec 31, 2021$641.00M+8.6%
Q3 FY2021Sep 30, 2021$599.90M+128.0%
Q2 FY2021Jun 30, 2021$460.10M-51.6%
Q1 FY2021Mar 31, 2021$574.20M-19.6%
Q4 FY2020Dec 31, 2020$590.30M-9.6%
Q3 FY2020Sep 30, 2020$263.10M-65.0%
Q2 FY2020Jun 30, 2020$950.40M+136.9%
Q1 FY2020Mar 31, 2020$714.30M+15.2%
Q4 FY2019Dec 31, 2019$653.30M+43.7%
Q3 FY2019Sep 30, 2019$752.60M+36.5%
Q2 FY2019Jun 30, 2019$401.20M-21.5%
Q1 FY2019Mar 31, 2019$620.10M-23.1%
Q4 FY2018Dec 31, 2018$454.60M+5.4%
Q3 FY2018Sep 30, 2018$551.30M+12.1%
Q2 FY2018Jun 30, 2018$511.40M+107.5%
Q1 FY2018Mar 31, 2018$806.80M+61.6%
Q4 FY2017Dec 31, 2017$431.50M-8.3%
Q3 FY2017Sep 30, 2017$491.90M–
Q2 FY2017Jun 30, 2017$246.40M–
Q1 FY2017Mar 31, 2017$499.40M–
Q4 FY2016Dec 31, 2016$470.70M–

More CME figures

See a number that looks wrong?